Johnson & Johnson vs Macrogen, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Johnson & Johnson is the larger company by market value: $652.5 B against $153 M for Macrogen, Inc., 4265 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Jan 5, 2024 for Macrogen, Inc.). Macrogen, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Dec 2022: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Johnson & Johnson JNJ · #23 in the world | Macrogen, Inc. 038290.KQ |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇰🇷 South Korea |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | — |
| Founded | 1886 | — |
| Size | ||
| Market cap | $652.5 B | $153 M* |
| Revenue | $94.2 B | — |
| Net income | $26.8 B | — |
| Employees | 138,200 | — |
| Valuation | ||
| P/E ratio | 40.5× | — |
| Price to sales | 6.6× | — |
| Price to book | 8.0× | — |
| Free cash flow yield | 3.0% | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Oct 2026 | Market cap Jan 2024 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Johnson & Johnson or Macrogen, Inc.?
Johnson & Johnson is the larger company by market value: $652.5 B against $153 M for Macrogen, Inc., 4265 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Jan 5, 2024 for Macrogen, Inc.). Macrogen, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
More about Johnson & Johnson
More about Macrogen, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.